{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:12:51Z","timestamp":1789153971604,"version":"build-2803163510"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:p>\n                    Breast cancer (BRCA) is one of the most common neoplastic diseases among the female population. There were 43,780 BRCA-related deaths, with a mortality rate of 15% in the United States in 2022. Therefore, it is necessary to screen and validate potential diagnostic and prognostic biomarkers related to BRCA through bioinformatics technology. The GSE42568 and GSE5364 datasets were obtained from the Gene Expression Omnibus database, and the Cancer Genome Atlas BRCA dataset was sourced from the Xena functional genomics platform. Differentially expressed genes were identified across these 3 BRCA datasets using Venn diagram software. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were carried to investigate the role of these genes and potential underlying mechanisms in BRCA. A protein-protein interaction network was constructed using the STRING database, and key genes were identified using the CytoHubba plugin in Cytoscape software. Hub genes were determined via Kaplan\u2013Meier survival analysis and were validated using the GEPIA, UALCAN platforms. In addition, the expression of these genes in tumor and adjacent tissues of BRCA patients was validated by reverse transcription quantitative polymerase chain reaction. A total of 84 overlapping differentially expressed genes were preliminarily screened at the initial stage, including 33 upregulated and 51 downregulated genes. The top 20 highly connected key genes were identified subsequently using Cytoscape software. These hub genes show good consistency with the progression of the BRCA. In addition, the results showed that the expression levels of these 5 hub genes are significantly different among BRCA subtypes, which may provide support for identifying BRCA subtypes and optimizing treatment strategies. Four hub genes (\n                    <jats:italic toggle=\"yes\">AURKA<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">DTL<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">NUSAP1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">RRM2<\/jats:italic>\n                    ) were finally identified through reverse transcription quantitative polymerase chain reaction. When compared to normal tissues, all of these genes exhibit high expression levels in BRCA tissues. The expression levels of\n                    <jats:italic toggle=\"yes\">AURKA<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">DTL<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">RRM2<\/jats:italic>\n                    are positively correlated with\n                    <jats:italic toggle=\"yes\">NUSAP1<\/jats:italic>\n                    , indicating a common regulatory relationship among these genes. Our present study demonstrated that\n                    <jats:italic toggle=\"yes\">AURKA<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">DTL<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">NUSAP1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">RRM2<\/jats:italic>\n                    are potential diagnostic and prognostic biomarkers for BRCA, and may also be potential treatment targets for clinical implication in the future.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043973","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:02:22Z","timestamp":1755543742000},"page":"e43973","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Weiwei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Central Laboratory, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yapei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5023-4724","authenticated-orcid":false,"given":"Cong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Liaocheng People\u2019s Hospital, Liaocheng, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.7150\/ijbs.21635","article-title":"Risk factors and preventions of breast cancer.","volume":"13","author":"Sun","year":"2017","journal-title":"Int J Biol Sci"},{"key":"R3-20260911","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/1055-9965.EPI-18-0098","article-title":"Proportion of U.S. trends in breast cancer incidence attributable to long-term changes in risk factor distributions.","volume":"27","author":"Pfeiffer","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/nu16050579","article-title":"Dietary patterns associated with breast cancer in the middle east: a scoping review.","volume":"16","author":"Zamzam","year":"2024","journal-title":"Nutrients"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"1292635","DOI":"10.3389\/fonc.2023.1292635","article-title":"The effect of an exopolysaccharide probiotic molecule from Bacillus subtilis on breast cancer cells.","volume":"13","author":"Nguyen","year":"2023","journal-title":"Front Oncol"},{"key":"R7-20260911","first-page":"1339","article-title":"Treatment of breast cancer.","volume":"81","author":"Maughan","year":"2010","journal-title":"Am Fam Physician"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-20301-6_4","article-title":"Breast cancer: current perspectives on the disease status.","volume":"1152","author":"Fahad Ullah","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-010-0746-x","article-title":"Combinatorial biomarker expression in breast cancer.","volume":"120","author":"Rakha","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41379-020-00704-7","article-title":"Prognostic and predictive parameters in breast pathology: a pathologist\u2019s primer.","volume":"34","author":"Allison","year":"2021","journal-title":"Mod Pathol"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer.","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"9041466","DOI":"10.1155\/2022\/9041466","article-title":"Identification and verification of key tumor genes associated with diagnosis and prognosis of breast cancer based on bioinformatics analysis.","volume":"2022","author":"Yu","year":"2022","journal-title":"Dis Markers"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update.","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists.","volume":"8","author":"Huang","year":"2007","journal-title":"Genome Biol"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life.","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses.","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005\u201320: an analysis of national mortality surveillance data.","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yexmp.2018.11.010","article-title":"Long non-coding RNAs and cervical cancer.","volume":"106","author":"Aalijahan","year":"2019","journal-title":"Exp Mol Pathol"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13104-023-06343-w","article-title":"Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research.","volume":"16","author":"Foruzandeh","year":"2023","journal-title":"BMC Res Notes"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"e22427","DOI":"10.1016\/j.heliyon.2023.e22427","article-title":"Usefulness of machine learning and deep learning approaches in screening and early detection of breast cancer.","volume":"9","author":"Ghorbian","year":"2023","journal-title":"Heliyon"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"e80166","DOI":"10.5812\/gct.80166","article-title":"Association of genetic variations in XRCC1 and ERCC1 genes with sporadic breast cancer.","volume":"5","author":"Ghorbian","year":"2018","journal-title":"Gene Cell Tissue"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0094-0143(05)70246-9","article-title":"Biological markers in superficial bladder tumors and their prognostic significance.","volume":"27","author":"Zlotta","year":"2000","journal-title":"Urol Clin North Am"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"e22826","DOI":"10.1002\/jcla.22826","article-title":"Association of the study between LncRNA-H19 gene polymorphisms with the risk of breast cancer.","volume":"33","author":"Abdollahzadeh","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"R26-20260911","doi-asserted-by":"crossref","first-page":"201343","DOI":"10.1016\/j.humgen.2024.201343","article-title":"Validation of gene polymorphisms (rs2682818 and rs2043556) in has-miR-618 and has-miR-605 with the breast cancer susceptibility.","volume":"42","author":"Hassani","year":"2024","journal-title":"Human Gene"},{"key":"R27-20260911","first-page":"291","article-title":"Correlation between Lsp1 (Rs3817198) and Casc (Rs4784227) polymorphisms and the susceptibility to breast cancer.","volume":"9","author":"Nourolahzadeh","year":"2020","journal-title":"Rep Biochem Mol Biol"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/sj.emboj.7601002","article-title":"Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.","volume":"25","author":"Nishitani","year":"2006","journal-title":"EMBO J"},{"key":"R29-20260911","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1038\/onc.2008.186","article-title":"Involvement of elevated expression of multiple cell-cycle regulator, DTL\/RAMP (denticleless\/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells.","volume":"27","author":"Ueki","year":"2008","journal-title":"Oncogene"},{"key":"R30-20260911","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/onc.2011.317","article-title":"1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.","volume":"31","author":"Mackintosh","year":"2012","journal-title":"Oncogene"},{"key":"R31-20260911","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjc.6605202","article-title":"Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer.","volume":"101","author":"Li","year":"2009","journal-title":"Br J Cancer"},{"key":"R32-20260911","doi-asserted-by":"crossref","first-page":"29680","DOI":"10.1074\/jbc.M113.495069","article-title":"Ubiquitin E3 ligase CRL4 (CDT2\/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer.","volume":"288","author":"Pan","year":"2013","journal-title":"J Biol Chem"},{"key":"R33-20260911","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4161\/cc.5.22.3500","article-title":"Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma.","volume":"5","author":"Pan","year":"2006","journal-title":"Cell Cycle"},{"key":"R34-20260911","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2019.06.006","article-title":"Identification of a functional polymorphism within the 3\u2032-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma.","volume":"118","author":"Yang","year":"2019","journal-title":"Eur J Cancer"},{"key":"R35-20260911","doi-asserted-by":"crossref","first-page":"e9266","DOI":"10.15252\/emmm.201809266","article-title":"Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.","volume":"11","author":"Uribesalgo","year":"2019","journal-title":"EMBO Mol Med"},{"key":"R36-20260911","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jamaoncol.2016.4975","article-title":"Androgen receptor function and androgen receptor-targeted therapies in breast cancer: a review.","volume":"3","author":"Kono","year":"2017","journal-title":"JAMA Oncol"},{"key":"R37-20260911","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1016\/S0021-9258(18)62745-0","article-title":"Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas.","volume":"245","author":"Elford","year":"1970","journal-title":"J Biol Chem"},{"key":"R38-20260911","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35003670","article-title":"p53 sends nucleotides to repair DNA.","volume":"404","author":"Lozano","year":"2000","journal-title":"Nature"},{"key":"R39-20260911","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","article-title":"Ribonucleotide reductase M2 (RRM2): regulation, function and targeting strategy in human cancer.","volume":"11","author":"Zuo","year":"2024","journal-title":"Genes Dis"},{"key":"R40-20260911","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1002\/jcp.26529","article-title":"RRM2 promotes the progression of human glioblastoma.","volume":"233","author":"Li","year":"2018","journal-title":"J Cell Physiol"},{"key":"R41-20260911","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.18632\/aging.202292","article-title":"High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.","volume":"13","author":"Jin","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R42-20260911","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/odi.13540","article-title":"Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.","volume":"27","author":"Wang","year":"2021","journal-title":"Oral Dis"},{"key":"R43-20260911","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1158\/1541-7786.MCR-13-0219","article-title":"AKT-induced tamoxifen resistance is overturned by RRM2 inhibition.","volume":"12","author":"Shah","year":"2014","journal-title":"Mol Cancer Res"},{"key":"R44-20260911","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41388-021-01711-x","article-title":"Aurora-A kinase oncogenic signaling mediates TGF-\u03b2-induced triple-negative breast cancer plasticity and chemoresistance.","volume":"40","author":"Jalalirad","year":"2021","journal-title":"Oncogene"},{"key":"R45-20260911","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy.","volume":"20","author":"Du","year":"2021","journal-title":"Mol Cancer"},{"issue":"Suppl 7","key":"R46-20260911","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12918-018-0634-2","article-title":"Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer.","volume":"12","author":"Guo","year":"2018","journal-title":"BMC Syst Biol"},{"key":"R47-20260911","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jid.2017.01.021","article-title":"AURKA overexpression is driven by FOXM1 and MAPK\/ERK activation in melanoma cells harboring BRAF or NRAS mutations: impact on melanoma prognosis and therapy.","volume":"137","author":"Puig-Butille","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R48-20260911","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1158\/1078-0432.CCR-06-2775","article-title":"Predictive value of Aurora-A\/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy.","volume":"13","author":"Lassmann","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R49-20260911","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2014.14","article-title":"The aurora kinases in cell cycle and leukemia.","volume":"34","author":"Goldenson","year":"2015","journal-title":"Oncogene"},{"key":"R50-20260911","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1038\/ncomms10180","article-title":"Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.","volume":"7","author":"Zheng","year":"2016","journal-title":"Nat Commun"},{"key":"R51-20260911","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1083\/jcb.200302129","article-title":"NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization.","volume":"162","author":"Raemaekers","year":"2003","journal-title":"J Cell Biol"},{"key":"R52-20260911","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.cellsig.2007.05.017","article-title":"NuSAP is degraded by APC\/C-Cdh1 and its overexpression results in mitotic arrest dependent of its microtubules\u2019 affinity.","volume":"19","author":"Li","year":"2007","journal-title":"Cell Signal"},{"key":"R53-20260911","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.7150\/jca.34640","article-title":"Decreased expression of NUSAP1 predicts poor overall survival in cervical cancer.","volume":"11","author":"Xie","year":"2020","journal-title":"J Cancer"},{"key":"R54-20260911","doi-asserted-by":"crossref","first-page":"e0221772","DOI":"10.1371\/journal.pone.0221772","article-title":"Identification of modules and functional analysis in CRC subtypes by integrated bioinformatics analysis.","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"R55-20260911","doi-asserted-by":"crossref","first-page":"108262","DOI":"10.1016\/j.clim.2019.108262","article-title":"Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.","volume":"210","author":"Wang","year":"2020","journal-title":"Clin Immunol"},{"key":"R56-20260911","doi-asserted-by":"crossref","first-page":"29935","DOI":"10.18632\/oncotarget.15604","article-title":"NUSAP1 promotes invasion and metastasis of prostate cancer.","volume":"8","author":"Gordon","year":"2017","journal-title":"Oncotarget"},{"key":"R57-20260911","first-page":"294","article-title":"ANKRD22 enhances breast cancer cell malignancy by activating the Wnt\/\u03b2-catenin pathway via modulating NuSAP1 expression.","volume":"21","author":"Wu","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"key":"R58-20260911","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.21037\/atm-21-5517","article-title":"NUSAP1 promotes the metastasis of breast cancer cells via the AMPK\/PPAR\u03b3 signaling pathway.","volume":"9","author":"Qiu","year":"2021","journal-title":"Ann Transl Med"},{"key":"R59-20260911","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12915-021-01103-3","article-title":"FGF-2 promotes angiogenesis through a SRSF1\/SRSF3\/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells.","volume":"19","author":"Jia","year":"2021","journal-title":"BMC Biol"},{"key":"R60-20260911","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1523\/JNEUROSCI.20-13-05012.2000","article-title":"Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex.","volume":"20","author":"Raballo","year":"2000","journal-title":"J Neurosci"},{"key":"R61-20260911","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fcell.2020.00079","article-title":"FGF signaling pathway: a key regulator of stem cell pluripotency.","volume":"8","author":"Mossahebi-Mohammadi","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R62-20260911","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molcel.2011.06.020","article-title":"FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1\/KDM2B-miR-101-EZH2 pathway.","volume":"43","author":"Kottakis","year":"2011","journal-title":"Mol Cell"},{"key":"R63-20260911","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013.","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"R64-20260911","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/s41467-018-04864-8","article-title":"Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program.","volume":"9","author":"Hirukawa","year":"2018","journal-title":"Nat Commun"},{"key":"R65-20260911","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncponc0509","article-title":"Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer.","volume":"3","author":"Nahta","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"R66-20260911","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours.","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"R67-20260911","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene.","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"R68-20260911","first-page":"1750","article-title":"Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.","volume":"57","author":"Wang","year":"1997","journal-title":"Cancer Res"},{"key":"R69-20260911","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.onc.1205128","article-title":"Basic fibroblast growth factor (bFGF)-induced cell death is mediated through a caspase-dependent and p53-independent cell death receptor pathway.","volume":"21","author":"Westwood","year":"2002","journal-title":"Oncogene"},{"key":"R70-20260911","doi-asserted-by":"crossref","first-page":"47912","DOI":"10.1074\/jbc.M409035200","article-title":"Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38MAPK and up-regulation of the death receptor p75NTR.","volume":"279","author":"Williamson","year":"2004","journal-title":"J Biol Chem"},{"key":"R71-20260911","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1242\/dev.128.11.2119","article-title":"STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2.","volume":"128","author":"Sahni","year":"2001","journal-title":"Development"},{"key":"R72-20260911","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1158\/0008-5472.CAN-08-0342","article-title":"Fibroblast growth factor 2 restrains Ras-driven proliferation of malignant cells by triggering RhoA-mediated senescence.","volume":"68","author":"Costa","year":"2008","journal-title":"Cancer Res"},{"key":"R73-20260911","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1357-2725(99)00133-8","article-title":"Fibroblast growth factor-2.","volume":"32","author":"Okada-Ban","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"key":"R74-20260911","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2008.10.011","article-title":"Aurora-A interacts with Cyclin B1 and enhances its stability.","volume":"275","author":"Qin","year":"2009","journal-title":"Cancer Lett"},{"key":"R75-20260911","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2443.2005.00870.x","article-title":"Over-expression of Aurora-A targets cytoplasmic polyadenylation element binding protein and promotes mRNA polyadenylation of Cdk1 and cyclin B1.","volume":"10","author":"Sasayama","year":"2005","journal-title":"Genes Cells"},{"key":"R76-20260911","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3858\/emm.2010.42.11.077","article-title":"Suppression of Aurora-A oncogenic potential by c-Myc downregulation.","volume":"42","author":"Yang","year":"2010","journal-title":"Exp Mol Med"},{"key":"R77-20260911","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00280-011-1618-8","article-title":"Efficacy and pharmacokinetic\/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer.","volume":"68","author":"Carol","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"R78-20260911","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1182\/blood-2009-12-259523","article-title":"A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.","volume":"115","author":"G\u00f6rg\u00fcn","year":"2010","journal-title":"Blood"},{"key":"R79-20260911","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/1541-7786.MCR-09-0300","article-title":"MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.","volume":"8","author":"Huck","year":"2010","journal-title":"Mol Cancer Res"},{"key":"R80-20260911","doi-asserted-by":"crossref","first-page":"26288","DOI":"10.1038\/s41598-024-76477-9","article-title":"DTL promotes the growth and migration of melanoma cells through the ERK\/E2F1\/BUB1 axis.","volume":"14","author":"Xuan","year":"2024","journal-title":"Sci Rep"},{"key":"R81-20260911","doi-asserted-by":"crossref","first-page":"287345","DOI":"10.1155\/2015\/287345","article-title":"RRM2B-mediated regulation of mitochondrial activity and inflammation under oxidative stress.","volume":"2015","author":"Cho","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R82-20260911","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/ani13122038","article-title":"Potential role of ribonucleotide reductase enzyme in mitochondria function and woody breast condition in broiler chickens.","volume":"13","author":"Shakeri","year":"2023","journal-title":"Animals (Basel)"},{"key":"R83-20260911","first-page":"100887","article-title":"A novel RRM2B mutation associated with mitochondrial DNA depletion syndrome.","volume":"32","author":"Fumagalli","year":"2022","journal-title":"Mol Genet Metab Rep"},{"key":"R84-20260911","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cbf.3444","article-title":"Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.","volume":"38","author":"Ge","year":"2020","journal-title":"Cell Biochem Funct"},{"key":"R85-20260911","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1002\/jcb.29661","article-title":"The role of nucleolar spindle-associated protein 1 in human ovarian cancer.","volume":"121","author":"Zhang","year":"2020","journal-title":"J Cell Biochem"},{"key":"R86-20260911","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.2147\/IJGM.S414270","article-title":"Expression profile and gene regulation network of NUSAP1 in pan cancers based on integrated bioinformatics analysis.","volume":"16","author":"Zhu","year":"2023","journal-title":"Int J Gen Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:01:39Z","timestamp":1789153299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":86,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043973","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"2024-12-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}